Richard M. Goldberg, MD, FAnnual Meeting of West Virginia University Cancer Institute explains how he defines a high-risk from a low-risk stage III colon cancer patient at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
“High-risk” versus “low-risk” stage III colon cancer patients
